NCT00393380 · FLOW
Participant flow
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- groups
- description
- Parathyroid hormone after double umbilical cord blood transplant.
- id
- FG000
- title
- Parathyroid Hormone (Teriparatide)
- periods
- milestones
- achievements
- group Id
- FG000
- num Subjects
- 13
- type
- STARTED
- achievements
- group Id
- FG000
- num Subjects
- 13
- type
- COMPLETED
- achievements
- group Id
- FG000
- num Subjects
- 0
- type
- NOT COMPLETED
- title
- Overall Study
- pre Assignment Details
- Thirteen patients who were enrolled proceeded to the cord blood transplant.
- recruitment Details
- Thirteen patients were enrolled on the study between October 25, 2006 and March 27, 2008 from three centers. Dana Farber Cancer Institute enrolled 10 patients, University of Florida enrolled 2 patients and Massachusetts General Hospital enrolled 1 patient.
Complete source fields
- groups
- description
- Parathyroid hormone after double umbilical cord blood transplant.
- id
- FG000
- title
- Parathyroid Hormone (Teriparatide)
- periods
- milestones
- achievements
- group Id
- FG000
- num Subjects
- 13
- type
- STARTED
- achievements
- group Id
- FG000
- num Subjects
- 13
- type
- COMPLETED
- achievements
- group Id
- FG000
- num Subjects
- 0
- type
- NOT COMPLETED
- title
- Overall Study
- pre Assignment Details
- Thirteen patients who were enrolled proceeded to the cord blood transplant.
- recruitment Details
- Thirteen patients were enrolled on the study between October 25, 2006 and March 27, 2008 from three centers. Dana Farber Cancer Institute enrolled 10 patients, University of Florida enrolled 2 patients and Massachusetts General Hospital enrolled 1 patient.
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle